ACADIA Pharmaceuticals, Inc. (ACAD) to Announce Third Quarter 2012 Financial Results on November 5, 2012
10/29/2012 7:09:15 AM
SAN DIEGO--(BUSINESS WIRE)--ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on innovative treatments that address unmet medical needs in neurological and related central nervous system disorders, today announced that it will report its unaudited financial results for the third quarter ended September 30, 2012 on Monday, November 5, 2012, after the U.S. financial markets close. ACADIA's management will host a conference call and webcast on Monday, November 5, 2012, at 5:00 p.m. Eastern Time to discuss ACADIA’s financial results and development programs.
comments powered by